APA

Janssen Y. J., Helmerhorst F., Frölich M. & Roelfsema F. (20000203). A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. : The Journal of clinical endocrinology and metabolism.

Chicago

Janssen Y J, Helmerhorst F, Frölich M and Roelfsema F. 20000203. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. : The Journal of clinical endocrinology and metabolism.

Harvard

Janssen Y. J., Helmerhorst F., Frölich M. and Roelfsema F. (20000203). A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. : The Journal of clinical endocrinology and metabolism.

MLA

Janssen Y J, Helmerhorst F, Frölich M and Roelfsema F. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. : The Journal of clinical endocrinology and metabolism. 20000203.